3-Methoxy-4-ethoxyphenethylamine
|
Names
|
Preferred IUPAC name
2-(4-Ethoxy-3-methoxyphenyl)ethan-1-amine
|
Identifiers
|
|
|
|
|
ChemSpider
|
|
ECHA InfoCard
|
100.199.597
|
EC Number
|
|
|
|
UNII
|
|
|
|
InChI=1S/C11H17NO2/c1-3-14-10-5-4-9(6-7-12)8-11(10)13-2/h4-5,8H,3,6-7,12H2,1-2H3 YKey: AFMUTJRFLRYILG-UHFFFAOYSA-N YInChI=1/C11H17NO2/c1-3-14-10-5-4-9(6-7-12)8-11(10)13-2/h4-5,8H,3,6-7,12H2,1-2H3 Key: AFMUTJRFLRYILG-UHFFFAOYAD
|
COc1cc(ccc1OCC)CCN O(c1ccc(cc1OC)CCN)CC
|
Properties
|
|
C11H17NO2
|
Molar mass
|
195.262 g·mol−1
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
3-Methoxy-4-ethoxyphenethylamine (MEPEA) is a lesser-known psychedelic drug. It was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 300 mg, and the duration unknown.[1] MEPEA is said to produce a light lifting feeling and a +1 on the Shulgin Rating Scale. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEPEA.
See also
References